Advancing Nuclear Medicine Through Innovation (häftad)
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
176
Utgivningsdatum
2007-10-01
Förlag
National Academies Press
Medarbetare
National Research Council (förf)
Illustrationer
Illustrations (some col.)
Dimensioner
229 x 153 x 11 mm
Vikt
395 g
Antal komponenter
1
ISBN
9780309110679

Advancing Nuclear Medicine Through Innovation

Häftad,  Engelska, 2007-10-01
742
  • Skickas från oss inom 5-8 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 2 format & utgåvor
Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized. Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.
Visa hela texten

Passar bra ihop

  1. Advancing Nuclear Medicine Through Innovation
  2. +
  3. Co-Intelligence

De som köpt den här boken har ofta också köpt Co-Intelligence av Ethan Mollick (häftad).

Köp båda 2 för 970 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Övrig information

Committee on State of the Science of Nuclear Medicine, National Research Council

Innehållsförteckning

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Nuclear Medicine; 5 3 Nuclear Medicine Imaging in Diagnosis and Treatment; 6 4 Targeted Radionuclide Therapy; 7 5 Availability of Radionuclides for Nuclear Medicine Research; 8 6 Radiotracer and Radiopharmaceutical Chemistry; 9 7 Instrumentation and Computational Sciences; 10 8 Education and Training of Nuclear Medicine Personnel; 11 References; 12 Appendix A Information-Gathering Sessions; 13 Appendix B Glossary and Acronyms; 14 Appendix C Commercially Available Radiopharmaceuticals; 15 Appendix D Biographical Sketches Of Committee Members